Melbourne, Victoria, Australia.
+61 3 8559 6530
Subscribe
Email Us
Collaborate Now

Melanoma Journal Articles for April 2017

Cancer Immunology, Immunotherapy

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment

Gülçin Gezgin, Mehmet Dogrusöz, T. Huibertus van Essen, Wilhelmina G. M. Kroes, Gregorius P. M. Luyten, Pieter A. van der Velden, Vonn Walter, Robert M. Verdijk, Thorbald van Hall, Sjoerd H. van der Burg, Martine J. Jager

 

Open Access

Original Article

First Online: 08 April 2017 DOI: 10.1007/s00262-017-1991-1

Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy

Jakob Siedlecki, Veronika Reiterer, Simon Leicht, Paul Foerster, Karsten Kortüm, Ulrich Schaller, Siegfried Priglinger, Christoph Fuerweger, Alexander Muacevic, Kirsten Eibl-Lindner

 

  • First published:7 April 2017
  • DOI:1111/aos.13418

Science Immunology

Resident memory T cells in the skin mediate durable immunity to melanoma

  1. Brian T. Malik1,
  2. Katelyn T. Byrne1,2,
  3. Jennifer L. Vella1,
  4. Peisheng Zhang1,
  5. Tamer B. Shabaneh1,
  6. Shannon M. Steinberg1,
  7. Aleksey K. Molodtsov1,
  8. Jacob S. Bowers3,
  9. Christina V. Angeles4,5,
  10. Chrystal M. Paulos3,
  11. Yina H. Huang1,5and 
  12. Mary Jo Turk1,5,*

 

Science Immunology  14 Apr 2017:
Vol. 2, Issue 10, eaam6346
DOI: 10.1126/sciimmunol.aam6346

BMJ Case Reports 2017; doi:10.1136/bcr-2016-217908

A tenebrous tale: malignant melanoma of the oesophagus

  1. Jane O’Sullivan1,
  2. Justin Matthias Hintze1,2,
  3. Peter Molony3,
  4. Donal B O’Connor4,5,
  5. Kevin C Conlan4,5

 

  • Accepted 19 March 2017
  • Published 24 April 2017

Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivo

  • Xinming Han, Yan Han, Yongsheng Zheng, Qiang Sun, Tao Ma, Junyi Zhang, Lianji Xu

Brachytherapy and anterior segment imaging in iris melanoma

ecancer 11 734 / DOI: 10.3332/ecancer.2017.734

Jin Soo Andy Song, Adam A Dmytriw and Hersham Lakosha

NATURE REVIEWS CLINICAL ONCOLOGY | RESEARCH HIGHLIGHT

IMMUNOTHERAPY 

Cul-TIL-vating uveal melanoma regression

Lisa Hutchinson

 

Nature Reviews Clinical Oncology (2017)

doi:10.1038/nrclinonc.2017.61

Published online 25 April 2017

Cancer Immunology, Immunotherapy

pp 1–10

The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case series

Xizhi Wen, Ya Ding, Jingjing Li, Jingjing Zhao, Ruiqing Peng, Dandan Li, Baoyan Zhu, Yao Wang, Xing Zhang, Xiaoshi Zhang

 

First Online: 25 April 2017

DOI: 10.1007/s00262-017-1989-8

Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression

Fiziev et al., 2017, Cell Reports 19, 875–889 April 25, 2017 ª 2017 The Author(s). http://dx.doi.org/10.1016/j.celrep.2017.03.078

IQGAP1 is an oncogenic target in canine melanoma

Becky H. Lee, Poornima H. Neela, Michael S. Kent, Ashley M. Zehnder

Correlation of histopathologic characteristics to protein expression and function in malignant melanoma

Charlotte Welinder, Krzysztof Paw?owski, A. Marcell Szasz, Maria Yakovleva, Yutaka Sugihara, Johan Malm, Göran Jönsson, Christian Ingvar, Lotta Lundgren, Bo Baldetorp, Håkan Olsson, Melinda Rezeli, Thomas  Laurell, Elisabet Wieslander, György Marko-Varga

  • Published: April 26, 2017
  • https://doi.org/10.1371/journal.pone.0176167

Clinical Cancer Research

Feasibility of ultra-high-throughput functional screening of melanoma biopsies for discovery of novel cancer drug combinations

Adam A. Friedman, Yun Xia, Lorenzo Trippa, Long P. Le, Vivien Igras, Dennie T Frederick, Jennifer A. Wargo, Kenneth K. Tanabe, Donald P Lawrence, Donna S Neuberg, Keith T. Flaherty and David Fisher

DOI: 10.1158/1078-0432.CCR-16-3029 Published January 2017

Oncotarget

SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes

Stefania Madonna1, Claudia Scarponi1, Martina Morelli1, Rosanna Sestito1,3, Pasqualina Liana Scognamiglio2, Daniela Marasco2, Cristina Albanesi1

Oncotarget. 2017; 8:24652-24667. doi: 10.18632/oncotarget.15629

The Journal of Experimental Medicine

An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition

Helen L. Young,  View ORCID ProfileEmily J. Rowling,  View ORCID ProfileMattia Bugatti,  View ORCID ProfileEmanuele Giurisato, Nadia Luheshi, Imanol Arozarena, Juan-Carlos Acosta, Jivko Kamarashev, Dennie T. Frederick, Zachary A. Cooper,  View ORCID ProfileAlexandre Reuben,  View ORCID ProfileJesus Gil, Keith T. Flaherty,  View ORCID ProfileJennifer A. Wargo,  View ORCID ProfileWilliam Vermi, Michael P. Smith, Claudia Wellbrock,  View ORCID ProfileAdam Hurlstone

DOI: 10.1084/jem.20160855 | Published April 27, 2017

JAMA Dermatology

Utility of a Noninvasive 2-Gene Molecular Assay for Cutaneous Melanoma and Effect on the Decision to Biopsy

Laura K. Ferris, MD, PhD1; Burkhard Jansen, MD2; Jonhan Ho, MD1; et alKlaus J. Busam, MD3; Kenneth Gross, MD4; Doyle D. Hansen, MD5; John P. Alsobrook II, PhD2; Zuxu Yao, PhD2; Gary L. Peck, MD6; Pedram Gerami, MD7

JAMA Dermatol. Published online April 26, 2017. doi:10.1001/jamadermatol.2017.0473

Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients

Nijenhuis, C M; Huitema, A D R; Blank, C; Haanen, J B A G; van Thienen, J V; Rosing, H; Schellens, J H M; Beijnen, J H

(2017) Journal of Clinical Pharmacology, volume 57, issue 1, pp. 125 – 128

(Article)

JAMA Ophthalmology

PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma

Gülçin Gezgin, MD1; Sietse J. Luk, BSc2; Jinfeng Cao, MD1,3; et alMehmet Dogrusöz, MD1; Dirk M. van der Steen, Dipl-ing2; Renate S. Hagedoorn, Dipl-ing2; Daniëlle Krijgsman, BSc1; Pieter A. van der Velden, PhD1; Matthew G. Field, MSc4; Gregorius P. M. Luyten, MD, PhD1; Karoly Szuhai, PhD5; J. William Harbour, MD, PhD4; Ekaterina S. Jordanova, PhD6,7; Mirjam H. M. Heemskerk, PhD2; Martine J. Jager, MD, PhD1

JAMA Ophthalmol. Published online April 27, 2017. doi:10.1001/jamaophthalmol.2017.0729

 

Menu